Secukinumab induced Behçet’s syndrome: a report of two cases

Secukinumab is a human monoclonal antibody against IL-17A that has been shown to be effective in psoriasis, psoriatic arthritis and ankylosing spondylitis (AS). On the other hand, in randomized controlled trials among patients with Crohn’s disease (CD) and uveitis due to Behçet’s syndrome (BS) treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dincses, Elif, Yurttas, Berna, Esatoglu, Sinem N, Melikoglu, Melike, Hamuryudan, Vedat, Seyahi, Emire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544425/
https://www.ncbi.nlm.nih.gov/pubmed/31198577
http://dx.doi.org/10.1093/omcr/omz041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544425/
https://www.ncbi.nlm.nih.gov/pubmed/31198577
http://dx.doi.org/10.1093/omcr/omz041

Ejemplares similares